Koios Beverage Corp (FITSF)

[PotterBanker]

Clinical Trial Shows Positive Brain Activity Linked to Koios Beverages

https://www.newswire.ca/news-releases/clinical-trial-shows-positive-brain-activity-linked-to-koios-beverages-696153001.html

VANCOUVER, Oct. 9, 2018 /CNW/ - The preliminary findings on clinical trials into the cognitive benefit of nootropic beverages made by Koios Beverage Corp.(CSE: KBEV) (OTC: KBEVF:US) (the "Company" or "Koios"), indicate positive brain results, the Company reported today.

So far, full clinical brain scans on Koios users show changes in brain activity in three main areas, all of which indicate improved cognitive function.

"The findings, although preliminary, are better than we could have expected," said Chris Miller, CEO of the Company. "Changes in the type of brain activity that we are seeing between the baseline that was mapped at the start of the study, and the effect on participants after several months of consuming our beverages, could have many positive implications."